Labshake search
Citations for R&D Systems :
901 - 950 of 2809 citations for Recombinant Human MSLN Protein Fc Avi tagged Biotinylated since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Neuroscience 2022Quote: ... 5 μg/ml of TGF-β RII Fc chimera (TGF-β RII Fc) (R&D Systems), was applied to SN cultures 1 h prior to fixation to inhibit TGF-β signaling ...
-
bioRxiv - Bioengineering 2022Quote: ... and biotinylated EGFR antibodies (BAF231, R&D Systems) were used at the detection step at concentrations of 5 μg/mL ...
-
bioRxiv - Physiology 2021Quote: ... and biotinylated goat IgG (BAF108, R&D Systems). Cells were washed and incubated 30 min with Streptavidin-APC/Cy7 and the viability dye 7-aminoactinomycin D (7-AAD ...
-
bioRxiv - Cancer Biology 2023Quote: ... a biotinylated AXL antibody (R&D systems BAF154) was used and for p-AXL measurements a pan-tyrosine biotinylated antibody (R&D systems BAM1676 ...
-
bioRxiv - Immunology 2021Quote: ... recombinant MBL (R&D systems) (100 µg mL-1 ...
-
bioRxiv - Bioengineering 2022Quote: ... Recombinant LOXL2 (R&D Systems) was used as a positive control.
-
bioRxiv - Genomics 2019Quote: ... as from previous dose-response experiments3–5: recombinant human IL-1β (specific activity 1.8×107 U/mg; 201-LB-005, R&D Systems, Abingdon, UK) at 50 U/ml ...
-
bioRxiv - Immunology 2020Quote: ... Cultures were supplemented 2 days later with 1.25 ml of R15 containing 100 U/ml recombinant human IL-2 (R&D systems; R15-100). R15-100 was added every 2 to 3 days thereafter ...
-
bioRxiv - Cell Biology 2022Quote: MC3T3 cells were cultured in growth media and treated with increasing concentrations of recombinant human CXCL12/SDF-1α (R&D Systems, #350-NS) reconstituted in PBS and 0.1% BSA in a 24-well trans-well plate and allowed to migrate for 3 hours prior to cell quantification.
-
bioRxiv - Neuroscience 2023Quote: ... the cells were cultivated in neural progenitor medium based on 2D-NIM medium without the dual SMAD inhibitors SB-431542 and LDN-193189 and supplemented with 20 ng/mL recombinant human basic FGF (#233-FB, R&D Systems, Germany) and 10 µM Y-27632 (only for the first 24 h after passaging) ...
-
bioRxiv - Cancer Biology 2023Quote: ... washed twice and resuspended in T-cell migration media (RPMI + 1% FBS) with or without recombinant human CXCL12 (R&D Systems, 350-NS). PBMC (50,000 ...
-
bioRxiv - Genomics 2024Quote: ... 5 mM beta-glycerophosphate and 1% insulin-transferrin-selenous acid (osteogenic media) and stimulated them the next day with recombinant human BMP2 (300 ng/ml) (R&D Systems, MN) in serum-free osteogenic media ...
-
bioRxiv - Immunology 2023Quote: ... in PBS and HUVECs were plated at confluence and were stimulated with 40 ng/ml recombinant human TNF-α (210-TA; R&D Systems) and/or 50 ng/ml IFN-γ (285-IF ...
-
bioRxiv - Bioengineering 2024Quote: ... one T25 tissue culture flask was given media spiked with 1 ng/mL recombinant human TNF-α (R&D Systems, Cat. # 210-TA) (stimulated group ...
-
bioRxiv - Microbiology 2024Quote: ... The cell-free supernatants were incubated with an equal volume of 1 mg/ml of recombinant human IL-8 (R&D Systems, USA) at 37°C for 2h ...
-
bioRxiv - Zoology 2022Quote: ... The transfected cells were cultured in iPSC medium with 200 ng/mL of recombinant viral B18R protein (R&D Systems). B18R was removal once the transfected cells were ready to re-seed onto irradiated MEFs.
-
bioRxiv - Microbiology 2023Quote: ... coli were made from twice passaged nutrient broth cultures and incubated with 3 uM HMGB1 recombinant protein (R&D systems) reconstituted in 1mM DTT ...
-
bioRxiv - Cancer Biology 2023Quote: ... cells were treated with 1 μg/mL of either human rPD-1 (hrPD-1-Fc; R&D Systems #1086-PD-050; Minneapolis, MN, USA) or mouse rPD-1-Fc (R&D Systems #1021-PD-100 ...
-
bioRxiv - Cancer Biology 2019Quote: ... or ULBP4-Fc (R&D Systems) coated onto microtiter plates ...
-
bioRxiv - Immunology 2020Quote: ... mouse ICAM1-Fc (R&D systems), FxCycle Violet Stain ...
-
bioRxiv - Cancer Biology 2023Quote: ... EphrinB1-Fc (R&D systems, USA) and control Fc fragment (R&D Systems ...
-
bioRxiv - Synthetic Biology 2020Quote: ... Myc-tagged and V5-tagged CARs were stained using an Alexa Fluor 488-conjugated mouse anti-myc antibody (R&D Systems, IC3696G) and an Alexa Fluor 647-conjugated mouse anti-V5 antibody (Invitrogen ...
-
bioRxiv - Immunology 2019Quote: ... Recombinant DLL4 (#1389-D4) and recombinant Jagged-1 (#Q63722) were purchased from R&D systems and coated on plates at the same time as anti-CD3/anti-CD28 ...
-
bioRxiv - Immunology 2021Quote: ... Tissue culture 96-well plates were coated with DL4-Fc and VCAM-1-Fc (R&D Systems) overnight at 4°C or for 2-4 hours at room temperature ...
-
bioRxiv - Cancer Biology 2020Quote: ... mouse or rat collagen I (human, R&D Systems; mouse, Ray Biotech; rat, Yo Protein) or collagen III (human ...
-
bioRxiv - Systems Biology 2021Quote: ... and PE-conjugated antibodies against the following human proteins were obtained from R&D systems: TNFR1 (FAB225P) ...
-
bioRxiv - Cell Biology 2023Quote: ... Protein levels in ALFs were determined using custom Human Magnetic Luminex Assays (R&D Systems) for IFNγ ...
-
bioRxiv - Cell Biology 2020Quote: ... for 24 hours and rested overnight in C-RPMI with 100µM ferric ammonium citrate (FeAC) and 200U/ml of human recombinant IFN-γ (R&D Systems, MN USA) unless otherwise stated.
-
bioRxiv - Developmental Biology 2020Quote: Embryonic immortalised mouse epicardium-derived cells (mEPDC) were treated with 2.0 µg/ml human recombinant transforming growth factor (TGF)-β (R&D Systems; 240-B) for 30 hrs to induce EMT ...
-
bioRxiv - Bioengineering 2020Quote: ... Microvascular fragment-containing gels were cultured in serum-free media supplemented with 10 ng/mL recombinant human vascular endothelial growth factor (rhVEGF; R&D Systems, Minneapolis, MN) (55) ...
-
bioRxiv - Molecular Biology 2019Quote: ... cells were serum starved overnight and then incubated with 10 ng/ml recombinant human transforming growth factor-beta 1 (TGF-β1) (R&D Systems, Minneapolis, MN) for indicated times.
-
bioRxiv - Genetics 2020Quote: ... culture medium was replaced with KSR medium (Chambers et al., 2009, 2011) supplemented with 200 ng/ml of recombinant human Noggin (R&D Systems, Minneapolis, USA) and 10 μM of SB431542 (Sigma-Aldrich) ...
-
bioRxiv - Immunology 2021Quote: ... cells were starved for 5 hours in DermaLife Basal Medium followed by stimulation with human recombinant IL-17A (R&D systems, 50 ng/ml) and TNF-α (R&D systems ...
-
bioRxiv - Immunology 2022Quote: ... Five million PBMC were suspended in 40 ml R10 supplemented with 10 ng/ml recombinant human IL-2 (R&D Systems, 202-IL-050) together with 10 million K562-mbIL21-41BBL feeder cells irradiated with 100 Gy ...
-
bioRxiv - Cell Biology 2024Quote: ... Naïve T-cells were incubated in complete medium supplemented with 10 IU/mL recombinant human IL-2 (R&D Systems, 202-IL-050/CF). As a positive control ...
-
bioRxiv - Bioengineering 2024Quote: ... foregut cells in the 24-well plate or on the pillar plate were cultured in advanced DMEM/F12 supplemented with 5 ng/mL recombinant human FGF basic/FGF2/bFGF (R&D systems; 233-FB), 10 ng/mL recombinant human VEGF-165 (Gibco ...
-
bioRxiv - Bioengineering 2024Quote: Dye-labeled antimicrobial therapeutics (VHHα-(ABD)2-(EEG)6-Sx-POL-Cy7 or VHH16-ABD-(EEG)6-S17-PNT4-sulfo-Cy7) were incubated with recombinant human ADAM10 (R&D Systems, MN, U.S.A.) at 10 μM and 250 nM final concentrations respectively ...
-
bioRxiv - Bioengineering 2024Quote: ... foregut cells in the 24-well plate were cultured in DMEM base medium supplemented with 5 ng/mL recombinant human FGF basic/FGF2/bFGF (R&D systems; 233-FB), 10 ng/mL recombinant human VEGF-165 (Gibco ...
-
bioRxiv - Molecular Biology 2023Quote: ... cells were maintained in serum-starved media with or without 10ng/ml of recombinant human TGF-β1 (R&D Systems, cat 240-B/CF) for 48 hours and harvested ...
-
bioRxiv - Physiology 2023Quote: ... 1nM) in VEH for 60 minutes prior to the addition of recombinant human TGF-β1 (5 ng/ml; R&D Systems, Minneapolis, MN, USA). At 6 ...
-
bioRxiv - Cancer Biology 2023Quote: ... TF1 cells were cultured in RPMI-1640 with 10% FBS and 1 ng/mL recombinant human granulocyte–macrophage colony-stimulating factor (rhGM-CSF, No. 215-GM, R&D Systems, Minneapolis, MN). 293T cells were cultured in DMEM media containing 10% FBS ...
-
bioRxiv - Immunology 2021Quote: ... Nunc® Maxisorp™ 384-well plates were coated with 6 µg/ml of recombinant mouse pIgR protein (R&D Systems) diluted in coating solution concentrate (Seracare ...
-
bioRxiv - Immunology 2021Quote: ... recombinant proteins representing either full-length mouse ANGPTL3 or the N-terminal domain of mouse ANGPTL3 (R&D Systems, Minneapolis, MN), or the N-terminal domain of human ANGPTL4 (R&D Systems ...
-
bioRxiv - Physiology 2023Quote: ... Activity was calculated based on a standard curve determined using purified recombinant mouse myeloperoxidase protein (R&D Systems; Catalog# 3667-MP).
-
bioRxiv - Cancer Biology 2023Quote: We assessed binding to a library of 300 glycan structures for Fc fusion proteins sourced from a commercial vendor (R&D Systems) composed of a fusion of Siglec-3 ...
-
bioRxiv - Immunology 2023Quote: ... KIR2DL3*001 (#2014-KR-050) and KIR2DS4*001 (#1847-KR-050) KIR-Ig (KIR-Fc) fusion proteins were purchased from R&D systems. KIR2DS1*001-Fc was custom produced by Sino Biological ...
-
bioRxiv - Neuroscience 2023Quote: ... co-cultures were maintained for 24 hours in the control condition or in the presence of the chimera proteins Fc-LGR4 (8077-GP, R&D Systems), Fc-LGR5 (8078-GP ...
-
bioRxiv - Immunology 2024Quote: ... For activation endothelial cells were incubated with hMDM conditioned media for 6 h in absence or presence of TNFRII/TNFRSF1B-Fc chimera protein (726-R2-050, R&D Systems) at 1 µg/ml.
-
bioRxiv - Developmental Biology 2022Quote: Primary antibodies against GATA4 biotinylated (R&D systems, AF2606), SOX2 (Cell Signaling ...
-
bioRxiv - Cell Biology 2019Quote: ... biotinylated SCD4 was detected with Tetramethylbenzidine (R&D systems).